Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 2, 2020, after the close
10-Q filed Nov 3, 2020, 34 days after period end · 0001299130-20-000148
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $19.08M | $21.92M | $18.16M | $23.55M |
| Net Income | -$23.71M | -$29.12M | -$25.04M | -$22.02M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.14 |
| -$0.19 |
| -$0.19 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
